FDA-Drug2021-11-10Class I
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
MERCK SHARP & DOHME CORP
Hazard
Presence of Particulate Matter: Identified as Glass Particles
Sold states
Nationwide within the United States
Affected count
76,163 vials
Manufactured in
1 Merck Dr, N/A, Whitehouse Station, NJ, United States
Products
Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0093-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief